These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17999269)

  • 21. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor structure in the Camberwell Assessment of Need-Patient Version: the correlations with dimensions of illness, personality and quality of life of schizophrenia patients.
    Ritsner MS; Lisker A; Arbitman M; Grinshpoon A
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):499-507. PubMed ID: 23066767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of intellectual functioning on symptoms and service use in schizophrenia.
    Chaplin R; Barley M; Cooper SJ; Kusel Y; McKendrick J; Stephenson D; Obuaya T; Stockton-Henderson J; O'Brien LS; Burns T
    J Intellect Disabil Res; 2006 Apr; 50(Pt 4):288-94. PubMed ID: 16507033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranking of outcome domains for use in real-time outcomes feedback laboratory by patients with schizophrenia.
    Pyne JM; Labbate C
    J Nerv Ment Dis; 2008 Apr; 196(4):336-9. PubMed ID: 18414130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of public mental health services in a random community sample.
    Short T; Thomas S; Luebbers S; Ogloff JR; Mullen P
    Aust N Z J Psychiatry; 2010 May; 44(5):475-81. PubMed ID: 20397791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach.
    Lipkovich IA; Deberdt W; Csernansky JG; Buckley P; Peuskens J; Kollack-Walker S; Rotelli M; Houston JP
    Psychiatry Res; 2009 Dec; 170(2-3):161-7. PubMed ID: 19897252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.
    Cuyún Carter GB; Milton DR; Ascher-Svanum H; Faries DE
    BMC Psychiatry; 2011 Aug; 11():143. PubMed ID: 21871092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Schizophr Res; 2013 Dec; 151(1-3):203-8. PubMed ID: 24183751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: the 24-month follow-up ACCESS II study.
    Schöttle D; Schimmelmann BG; Karow A; Ruppelt F; Sauerbier AL; Bussopulos A; Frieling M; Golks D; Kerstan A; Nika E; Schödlbauer M; Daubmann A; Wegscheider K; Lange M; Ohm G; Lange B; Meigel-Schleiff C; Naber D; Wiedemann K; Bock T; Lambert M
    J Clin Psychiatry; 2014 Dec; 75(12):1371-9. PubMed ID: 25188752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of community support services by middle-aged and older patients with psychotic disorders.
    Shaw WS; Patterson TL; Semple SJ; Halpain MC; Koch WL; Harris MJ; Grant I; Jeste DV
    Psychiatr Serv; 2000 Apr; 51(4):506-12. PubMed ID: 10737827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
    Hofer A; Rettenbacher MA; Widschwendter CG; Kemmler G; Hummer M; Fleischhacker WW
    Eur Arch Psychiatry Clin Neurosci; 2006 Jun; 256(4):246-55. PubMed ID: 16311896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is early intervention in psychosis cost-effective over the long term?
    Mihalopoulos C; Harris M; Henry L; Harrigan S; McGorry P
    Schizophr Bull; 2009 Sep; 35(5):909-18. PubMed ID: 19509308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study.
    Carr VJ; Neil AL; Halpin SA; Holmes S; Lewin TJ
    Aust N Z J Psychiatry; 2003 Feb; 37(1):31-40. PubMed ID: 12534654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care.
    Ritsner MS; Grinshpoon A
    Clin Schizophr Relat Psychoses; 2015; 9(3):125-34A. PubMed ID: 23491971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment costs and use of community mental health services for schizophrenia by age cohorts.
    Cuffel BJ; Jeste DV; Halpain M; Pratt C; Tarke H; Patterson TL
    Am J Psychiatry; 1996 Jul; 153(7):870-6. PubMed ID: 8659608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.